Kevin L. Brackman - 06 Sep 2023 Form 4 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Sep 2023, 17:00:28 UTC
Prior SEC filing
26 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin L. Brackman

Key filing fact

Kevin L. Brackman filed Form 4 for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN) on 08 Sep 2023.

Key facts

  • This page summarizes Kevin L. Brackman's Form 4 filing for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Sep 2023, 17:00.

Change

  • Previous filing in this sequence was filed on 26 Aug 2022.
  • Current net transaction value: -$14,746.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADN transaction

Common Stock

Sale

Transaction value
$14,746
Shares
-27,771
Change %
-14%
Price
$0.5310
Shares after
176,477
Date
06 Sep 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares automatically sold solely to satisfy income tax and withholding and remittance obligations in connection with the vesting of RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .